GPNX
NOTIFICATION PROCESSED BY IB
12/04/2022
Back to search
Official data from USPTO
ILLUMIVIZ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
12/04/2022
Trademark type
Word
Nice classes
5
Filing date
09/06/2021
Registration date
10/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2022
Last transaction
10/04/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
PARKS, KIMBERLY L
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SAMSUNG BIOEPIS CO., LTD.
Representatives
KAI International IP Law Firm
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating neovascular age-related macular degeneration; pharmaceutical preparations for treating diabetic macular edema; pharmaceutical preparations for the treatment of angiogenesis diseases and disorders; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; ocular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; preparations for medical usepreparationsbiological formulationsbiological preparationsantibody formulations and protein formulations for immunoregulation and for the treatment of immunologic disordersautoimmune diseasesinflammatory diseasesarthritiscancertumorcentral nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of inflammatory diseases; antidiabetic preparations; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical preparations for the prevention of ocular disorders or diseases; cardiovascular agents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; dietary supplements
Publications
History of USPTO decisions and trademark events.
16 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/14/2022
FIMP
FINAL DISPOSITION PROCESSED
11/14/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
11/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/19/2022
PUBO
PUBLISHED FOR OPPOSITION
07/19/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/29/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/29/2022
NPUB
NOTICE OF PUBLICATION
06/29/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2022
DOCK
ASSIGNED TO EXAMINER
06/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/04/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/28/2021
Continuous trademark protection
Get notified about every new filing that threatens ILLUMIVIZ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.